Sotera Health Company
Sotera Health Company（SHC）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
shc · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$24.00
Consensus
$21.50
+35.6% upside
Low
$18.00
Median: $22 · Last Close: $15.86
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$21.50
35.6% upside
High Target
$24
51.3%
Low Target
$18
13.5%
Current Price
$15.86
as of today
Based on analyst price targets, the SHC stock price prediction for the next 12 months ranges from $18 to $24. The consensus SHC price forecast of $21.50 implies 35.6% upside from the current price of $15.86.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $15.80 | ↓ 0.37% |
1-day model range: $15.76–$15.84. Peak: $15.84 (-0.37%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $14 | -10.3% |
| 2028 | $13 | -15.8% |
| 2029 | $13 | -18.9% |
| 2030 | $13 | -20.7% |
| 2031 | — | -21.8% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SHC · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-05 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-05-06 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-04-14 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-24 | Citigroup | Maintains | Buy→Buy |
| 2026-01-09 | Piper Sandler | Upgrade ↑ | Neutral→Overweight |
| 2025-11-05 | Barclays | Maintains | Overweight→Overweight |
| 2025-11-05 | JP Morgan | Maintains | Neutral→Neutral |
| 2025-11-05 | Piper Sandler | Maintains | Neutral→Neutral |
| 2025-10-02 | Barclays | Maintains | Overweight→Overweight |
| 2025-06-24 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Sotera Health Company (SHC) stock. Of the recent 64 rating actions, 8 were upgrades and 9 were downgrades. 12 analysts currently cover SHC.
分析师推荐趋势
SHC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1.2B
↓ 11.8% YoY
Revenue Next Year
$1.2B
↑ 7.0% YoY
EPS This Year
$0.84
EPS Next Year
$0.97
↑ 15.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast SHC EPS of $0.84 for the current fiscal year, based on estimates from 7 analysts. The SHC revenue forecast is $1.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SHC 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SHC 的共识目标价为 $21.50（+35.6% 上行空间），分析师共识为 Buy。
SHC 的短期预测（明日）为 $15.80（-0.37%）。 SHC 对 2027 年的股价预测均值为 $14。 SHC 对 2030 年的预测区间为 $12–$13。
Sotera Health Company 在 NASDAQ 上市，代码 SHC。SHC 在 2027 年的整体展望偏积极，在覆盖分析师中约 92% 对应 Buy 共识。
常见问题
SHC 预测 · 8 个问题根据 12 位华尔街分析师，SHC 的 12 个月平均目标价为 $21.50，最高 $24.00、最低 $18.00。若有图表，中位目标价可在上方查看。相对当前价 $15.86，隐含约 +35.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.